Medesis Pharma S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALMDP.PA research report →
About the company
Medesis Pharma S. A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments.
- CEO
- Jean-Claude Maurel MHB
- IPO
- 2021
- Employees
- 10
- HQ
- Montpellier, FR
Price Chart
- Market Cap
- $1.80M
- P/E
- -0.44
- P/S
- 6.00
- P/B
- -0.39
- EV/EBITDA
- -0.77
- Div Yield
- 0.00%
- Gross Margin
- -888.16%
- Op Margin
- -1409.62%
- Net Margin
- -1319.68%
- ROE
- 142.49%
- ROIC
- 412.18%
- Revenue
- $300.03K · 534.36%
- Net Income
- $-3,959,491 · -44.04%
- EPS
- $-0.80 · -26.98%
- Op Income
- $-4,229,341
- FCF YoY
- 0.00%
- 52W High
- $2.00
- 52W Low
- $0.30
- 50D MA
- $0.37
- 200D MA
- $0.50
- Beta
- 0.18
- Avg Volume
- 15.91K
Get TickerSpark's AI analysis on ALMDP.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALMDP.PA coverage
Recent articles, reports, and earnings notes.
No research on ALMDP.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALMDP.PA report →Similar companies
Peers in the same neighborhood.